Nicola Di Gaetano

Complement Activation Determines the Therapeutic Activity of Rituximab In Vivo

Nicola Di Gaetano, Elena Cittera, Rachele Nota et al. · The Journal of Immunology · 2003 · 563 citations · Full text

Life Sciences, Immunology, Oncology +16

Synergism between fludarabine and rituximab revealed in a follicular lymphoma cell line resistant to the cytotoxic activity of either drug alone

Nicola Di Gaetano, Yi Xiao, Eugenio Erba et al. · British Journal of Haematology · 2001 · 199 citations

Medicine, Immunology, Pharmacology +13

The role of complement in the therapeutic activity of rituximab in a murine B lymphoma model homing in lymph nodes.

Josée Golay, Elena Cittera, Nicola Di Gaetano et al. · PubMed · 2006 · 130 citations

Life Sciences, Immunology, Oncology +17

Gemtuzumab ozogamicin (Mylotarg) has therapeutic activity against CD33⁺ acute lymphoblastic leukaemias <i>in vitro</i> and <i>in vivo</i>

Josée Golay, Nicola Di Gaetano, Donatella Amico et al. · British Journal of Haematology · 2005 · 54 citations

Medicine, Hematology, Pharmacology +16

Reticulocyte count, mean reticulocyte volume, immature reticulocyte fraction, and mean sphered cell volume in elite athletes: reference values and comparison with the general population

Giuseppe Banfi, Clara Mauri, Benedetto Morelli et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 2006 · 35 citations

Medicine, Hematology, Sports Medicine +13